STOCK TITAN

Alto Ingredients (NASDAQ: ALTO) returns to profit with stronger Q1 2026 margins

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Alto Ingredients, Inc. reported a strong turnaround for the quarter ended March 31, 2026. Net sales were $224.7 million, while gross profit reached $9.2 million, an $11.0 million improvement from the prior year’s loss. Net income was $4.0 million, or $0.05 per share, improving by $16.0 million versus Q1 2025. Adjusted EBITDA rose to $4.7 million, up $9.1 million year over year, helped by stronger export sales, higher crush margins and contributions from Section 45Z tax credits. Cash and cash equivalents were $20.3 million with borrowing availability of $94.3 million, and total stockholders’ equity was $249.9 million.

Positive

  • Profitable turnaround: Q1 2026 net income of $4.0 million and Adjusted EBITDA of $4.7 million represent a $16.0 million and $9.1 million improvement, respectively, from Q1 2025, showing materially stronger profitability.

Negative

  • None.

Insights

Alto swings from loss to profit on better margins and tax credits.

Alto Ingredients delivered a notable earnings turnaround in Q1 2026. Net income reached $4.0M, or $0.05 per share, versus a loss in Q1 2025, while Adjusted EBITDA improved to $4.7M. Gross profit rose by $11.0M, indicating healthier unit economics.

Management cites stronger export sales, higher crush margins and incremental Section 45Z tax credits as key drivers, while net sales stayed roughly flat. Liquidity remains solid with $20.3M in cash and $94.3M of borrowing availability as of March 31, 2026, supporting ongoing optimization and capital projects.

The company also highlights plans to improve utilization and reliability, execute its 2026 optimization projects, and further monetize Section 45Z credits and biogenic CO2. Future filings may show how consistently these factors support profitability through commodity cycles and regulatory developments around Section 45Z.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Net sales $224.7M Three months ended March 31, 2026
Gross profit $9.2M Q1 2026; increased $11.0M vs Q1 2025
Net income $4.0M ($0.05/share) Q1 2026; improved $16.0M vs Q1 2025
Adjusted EBITDA $4.7M Q1 2026; improved $9.1M vs Q1 2025
Cash and cash equivalents $20.3M As of March 31, 2026
Borrowing availability $94.3M As of March 31, 2026 across credit facilities
Total stockholders’ equity $249.9M As of March 31, 2026 balance sheet
Average sales price per gallon $2.00 Q1 2026 alcohol sales pricing metric
Adjusted EBITDA financial
"Q1 2026 Adjusted EBITDA of $4.7 Million Improved $9.1 Million Compared to Q1 2025"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Section 45Z tax credits financial
"incremental earnings from Section 45Z tax credits"
biogenic CO2 technical
"optimally monetizing the value of our biogenic CO2 production across our facilities"
Board corn crush per gallons financial
"Board corn crush per gallons (1)"
Essential ingredients return % financial
"Essential ingredients return % (2)"
Net sales $224.7M
Net income $4.0M +$16.0M vs Q1 2025
Adjusted EBITDA $4.7M +$9.1M vs Q1 2025
false 0000778164 0000778164 2026-05-06 2026-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 6, 2026

 

ALTO INGREDIENTS, INC.

 

(Exact Name of Registrant as Specified in Charter)

 

Delaware   000-21467     41-2170618

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

1300 South Second Street

Pekin, Illinois

  61554
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code:  (833) 710-2586

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   ALTO  

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On May 6, 2026, Alto Ingredients, Inc. issued a press release announcing certain results of operations for the three months ended March 31, 2026. A copy of the press release is furnished (not filed) as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information furnished in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 2.02 of this Current Report on Form 8-K is not incorporated by reference into any filings of Alto Ingredients, Inc. made under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing unless specifically stated so therein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Number   Description
99.1   Press Release dated May 6, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  May 6, 2026 ALTO INGREDIENTS, INC.
     
  By: /s/ AUSTE M. GRAHAM
    Auste M. Graham,
    Chief Legal Officer and Secretary

 

2

Exhibit 99.1

 

 

 

Alto Ingredients, Inc. Reports First Quarter 2026 Results

 

Q1 2026 Gross Profit of $9.2 Million Increased $11.0 Million
Q1 2026 Net Income of $4.0 Million, or $0.05 per Share, Improved $16.0 Million
Q1 2026 Adjusted EBITDA of $4.7 Million Improved $9.1 Million Compared to Q1 2025

 

Pekin, Ill., May 6, 2026 – Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, reported its financial results for the quarter ended March 31, 2026.

 

“In a seasonally weak period for Alto and the industry, we delivered profitability on an adjusted EBITDA and net income basis through the contributions of strong export sales, higher crush margins and incremental earnings from Section 45Z tax credits. Even without the contribution of the tax credits we were profitable,” said President and Chief Executive Officer Bryon McGregor. “Our strategic realignment, combined with our efforts to improve our operational model and the stability of our business have enhanced our earnings power.”

 

Added Mr. McGregor, “Looking ahead, our priorities are straightforward: improve utilization and reliability; execute our 2026 optimization and capital projects on time and on budget; and leverage the flexibility we have with multiple revenue streams to respond to market shifts and perform profitably through commodity cycles. In addition, we are focused on expanding the value we capture from 45Z tax credits and on optimally monetizing the value of our biogenic CO2 production across our facilities to lower our carbon footprint. Through our focus on these priorities, we remain committed to enhancing the value of our assets.”

 

Financial Results for the Three Months Ended March 31, 2026 Compared to 2025

 

Net sales were $224.7 million, compared to $226.5 million.

 

Cost of goods sold was $215.5 million, compared to $228.3 million.

 

Gross profit was $9.2 million, compared to a gross loss of $1.8 million. Gross profit was positively impacted by an $8.1 million net unrealized gain on derivatives.

 

Selling, general and administrative expenses were $6.7 million, compared to $7.2 million.

 

Interest expense was $2.2 million, compared to $2.7 million.

 

Net income attributable to common stockholders was $4.0 million, or $0.05 per diluted share, compared to a net loss of $12.0 million, or $0.16 per share.

 

Adjusted EBITDA was $4.7 million, compared to negative $4.4 million, an increase of $9.1 million.

 

 

 

 

 

 

Cash and cash equivalents at March 31, 2026 were $20.3 million, compared to $23.4 million at December 31, 2025. The company’s borrowing availability at March 31, 2026 was $94.3 million, including $29.3 million under the company’s operating line of credit and $65 million under its term loan facility.

 

First Quarter 2026 Results Conference Call

 

Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Wednesday, May 6, 2026, and will deliver prepared remarks via webcast followed by a question-and-answer session.

 

To receive a number and unique PIN by email, register here. To dial directly up to 20 minutes prior to the scheduled call time, please dial (833) 630-0017 domestically and (412) 317-1806 internationally. Alternatively, the webcast for the conference call can be accessed from Alto Ingredients’ website at www.altoingredients.com and will be available for one year.

 

Use of Non-GAAP Measures

 

Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision (benefit) for income taxes, asset impairments, unrealized derivative gains and losses, acquisition-related expense, excess insurance proceeds and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.

 

About Alto Ingredients, Inc.

 

Alto Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients. Leveraging the unique qualities of its facilities, the company serves customers in a wide range of consumer and commercial products in the Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. For more information, please visit www.altoingredients.com.

 

2

 

 

 

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

 

Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ expectations around profitability and executing on opportunities to grow earnings, including through improved utilization and reliability, optimization and capital projects, monetizing additional Section 45Z tax credits and monetizing the value of its biogenic CO2 to lower its carbon footprint; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business and plans. These factors include, among others adverse economic and market conditions, including for renewable fuels, specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; adverse impacts of inflation and supply chain constraints, including from tariffs; Alto Ingredients’ ability to timely and within budget execute on its optimization and capital projects; Alto Ingredients’ ability to expand and monetize the value of its CO2 production to lower its carbon footprint; regulatory developments and Alto Ingredients’ ability to successfully pursue and secure opportunities, and realize the expected results, under existing and new legislation, including the Section 45Z regulations, and to successfully apply for and receive anticipated credit amounts. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the alcohol production, marketing and distribution industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 13, 2026.

 

Company IR and Media Contact:

 

Michael Kramer, Alto Ingredients, Inc., 916-403-2755

Investorrelations@altoingredients.com

 

IR Agency Contact:

 

Jody Burfening, Alliance Advisors Investor Relations, 212-838-3777,

Investorrelations@altoingredients.com 

 

3

 

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited, in thousands, except per share data)

 

   Three Months Ended
March 31,
 
   2026   2025 
Net sales  $224,680   $226,540 
Cost of goods sold   215,461    228,347 
Gross profit (loss)   9,219    (1,807)
Selling, general and administrative expenses   6,699   7,190
Income (loss) from operations   2,520    (8,997)
Interest expense, net   (2,198)   (2,729)
Transferable tax credits, net   3,900     
Other income, net   49    47 
Income (loss) before provision for income taxes   4,271    (11,679)
Provision for income taxes        
Net income (loss)  $4,271   $(11,679)
Preferred stock dividends  $(312)  $(312)
Net income (loss) attributable to common stockholders  $3,959   $(11,991)
Net income (loss) per share, basic  $0.05   $(0.16)
Net income (loss) per share, diluted  $0.05   $(0.16)
Weighted-average shares outstanding, basic   74,789    73,836 
Weighted-average shares outstanding, diluted   76,639    73,836 

 

4

 

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value)

 

ASSETS  March 31,
2026
   December 31,
2025
 
Current Assets:        
Cash and cash equivalents  $20,309   $23,415 
Restricted cash   1,334    2,258 
Accounts receivable, net   59,700    55,069 
Inventories   52,831    61,676 
Derivative instruments   7,831    525 
Transferable tax credits, net   11,530    7,500 
Other current assets   5,017    5,474 
Total current assets   158,552    155,917 
Property and equipment, net   193,199    198,501 
Other Assets:          
Right of use operating lease assets, net   17,215    16,931 
Intangible assets, net   7,419    7,574 
Other assets   9,908    9,863 
Total other assets   34,542    34,368 
Total Assets  $386,293   $388,786 

 

5

 

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(unaudited, in thousands, except par value)

 

LIABILITIES AND STOCKHOLDERS’ EQUITY  March 31,
2026
   December 31,
2025
 
Current Liabilities:        
Accounts payable  $19,303   $14,509 
Accrued liabilities   12,332    16,691 
Current portion – long-term debt       16,600 
Current portion – operating leases   4,975    4,958 
Derivative instruments   301    1,067 
Other current liabilities   4,741    5,246 
Total current liabilities   41,652    59,071 
           
Long-term debt   73,056    63,027 
Operating leases, net of current portion   13,240    13,012 
Other liabilities   8,467    8,435 
Total Liabilities   136,415    143,545 
           
Stockholders’ Equity:          
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: no shares issued and outstanding as of March 31, 2026 and December 31, 2025 Series B: 927 shares issued and outstanding as of March 31, 2026 and December 31, 2025   1    1 
Common stock, $0.001 par value; 300,000 shares authorized; 77,946 and 77,307 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively   78    77 
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of March 31, 2026 and December 31, 2025        
Additional paid-in capital   1,052,472    1,051,795 
Accumulated other comprehensive income   5,461    5,461 
Accumulated deficit   (808,134)   (812,093)
Total Stockholders’ Equity   249,878    245,241 
Total Liabilities and Stockholders’ Equity  $386,293   $388,786 

 

6

 

 

 

 

Reconciliation of Adjusted EBITDA to Net Income (Loss)

 

   Three Months Ended
March 31,
 
(in thousands) (unaudited)  2026   2025 
Net income (loss)  $4,271   $(11,679)
Adjustments:          
Interest expense   2,198    2,729 
Interest income   (77)   (84)
Unrealized derivatives gains   (8,073)   (1,634)
Depreciation and amortization expense   6,366    6,266 
Total adjustments   414    7,277 
Adjusted EBITDA  $4,685   $(4,402)

 

7

 

 

 

 

Segment Financials

 

(in thousands) (unaudited)  Three Months Ended
March 31,
 
   2026   2025 
Net sales        
Pekin Campus production:        
Alcohol sales  $107,952   $107,234 
Essential ingredient sales   43,993    44,618 
Intersegment sales   262    297 
Total Pekin Campus sales   152,207    152,149 
Marketing and distribution:          
Alcohol sales  $47,326   $49,058 
Intersegment sales   2,450    2,506 
Total marketing and distribution sales   49,776    51,564 
Western production:          
Alcohol sales  $16,680   $16,194 
Essential ingredient sales   7,280    7,808 
Intersegment sales   399    264 
Total Western production sales   24,359    24,266 
           
Corporate and other   1,449    1,628 
Intersegment eliminations   (3,111)   (3,067)
Net sales as reported  $224,680   $226,540 
Cost of goods sold:          
Pekin Campus production  $144,021   $155,222 
Marketing and distribution   46,037    47,650 
Western production   25,502    25,524 
Corporate and other   1,036    1,681 
Intersegment eliminations   (1,135)   (1,730)
Cost of goods sold as reported  $215,461   $228,347 
Gross profit (loss):          
Pekin Campus production  $8,186   $(3,073)
Marketing and distribution   3,739    3,914 
Western production   (1,143)   (1,258)
Corporate and other   413    (53)
Intersegment eliminations   (1,976)   (1,337)
Gross profit (loss) as reported  $9,219   $(1,807)

 

8

 

 

 

 

Sales and Operating Metrics (unaudited)

 

(in thousands) (unaudited)  Three Months Ended
March 31,
 
   2026   2025 
Alcohol Sales (gallons in millions)        
Pekin Campus renewable fuel gallons sold   31.2    32.6 
Western production renewable fuel gallons sold   8.2    8.3 
Third party renewable fuel gallons sold   23.5    24.4 
Total renewable fuel gallons sold   62.9    65.3 
Specialty alcohol gallons sold   23.0    24.3 
Total gallons sold   85.9    89.6 
           
Sales Price per Gallon          
Pekin Campus  $2.00   $1.90 
Western production  $2.03   $1.95 
Marketing and distribution  $2.01   $2.01 
Average sales price per gallon  $2.00   $1.93 
           
Alcohol Production (gallons in millions)          
Pekin Campus   51.2    54.3 
Western production   7.9    8.3 
Total   59.1    62.6 
           
Corn Cost per Bushel          
Pekin Campus  $4.45   $4.65 
Western production  $5.54   $5.95 
Total  $4.58   $4.81 

 

9

 

 

 

 

Sales and Operating Metrics (unaudited)

 

(in thousands) (unaudited)  Three Months Ended
March 31,
 
   2026   2025 
Average Market Metrics        
PLATTS Ethanol price per gallon  $1.73   $1.71 
CME Corn cost per bushel  $4.38   $4.72 
Board corn crush per gallons (1)  $0.17   $0.02 
           
Essential Ingredients Sold (thousand tons)          
Pekin Campus:          
Distillers grains   80.4    90.7 
CO2   43.3    45.3 
Corn wet feed   29.9    34.5 
Corn dry feed   21.0    23.8 
Corn oil and germ   18.1    19.6 
Corn meal   9.5    9.4 
Syrup and other   9.2    8.2 
Yeast   6.1    6.4 
Total Pekin Campus essential ingredients sold   217.5    237.9 
           
Western production:          
Distillers grains   60.1    58.1 
CO2   12.8    12.6 
Corn oil   0.8    1.4 
Syrup and other   0.8    0.8 
Total Western production essential ingredients sold   74.5    72.9 
           
Total Essential Ingredients Sold   292.0    310.8 
           
           
Essential ingredients return % (2)          
Pekin Campus return   54.0%   48.0%
Western production return   49.9%   49.0%
Consolidated total return   53.4%   48.2%

 

 

(1)Assumes corn conversion of 2.80 gallons of alcohol per bushel of corn.
(2)Essential ingredients revenues as a percentage of total corn costs consumed.

 

####

 

10

FAQ

How did Alto Ingredients (ALTO) perform financially in Q1 2026?

Alto Ingredients generated net sales of about $224.7 million in Q1 2026 and achieved net income of $4.0 million, or $0.05 per share. This marked a significant improvement from the prior-year loss and reflected stronger margins and tax credit contributions.

What was Alto Ingredients’ Adjusted EBITDA in Q1 2026?

Alto Ingredients reported Adjusted EBITDA of $4.7 million in Q1 2026. Management noted this figure improved by $9.1 million compared to Q1 2025, driven by higher crush margins, strong export sales and incremental Section 45Z transferable tax credits supporting overall profitability.

How did Alto Ingredients’ Q1 2026 results compare to Q1 2025?

In Q1 2026, Alto Ingredients’ gross profit was $9.2 million, increasing $11.0 million from Q1 2025, when it reported a gross loss. Net income improved by $16.0 million, moving from a net loss to a $4.0 million profit during the same period.

What role did Section 45Z tax credits play for Alto Ingredients (ALTO)?

Management highlighted Section 45Z tax credits as an incremental earnings contributor in Q1 2026. They also emphasized plans to expand and better monetize these transferable tax credits going forward as part of their strategy to support profitability and lower the company’s carbon footprint.

What is Alto Ingredients’ liquidity position as of March 31, 2026?

As of March 31, 2026, Alto Ingredients held $20.3 million in cash and cash equivalents and reported total borrowing availability of $94.3 million. This included $29.3 million under its operating line of credit and $65 million under its term loan facility.

How did Alto Ingredients’ segment performance contribute in Q1 2026?

In Q1 2026, the Pekin Campus segment generated gross profit of $8.2 million, while marketing and distribution added $3.7 million. Western production posted a small gross loss, and corporate and other activities remained modest, resulting in consolidated gross profit of $9.2 million.

Filing Exhibits & Attachments

4 documents